
    
      The study was designed as a prospective double blinded randomised controlled trial, comparing
      200µg to 400 µg misoprostol given vaginally at four hour intervals, starting 36-48 hours
      after the oral administration of mifepristone 200 mg at a gestational age between 14 to 24
      weeks.
    
  